Keywords: cambridge, biotech, sell, retroviral, diagnostic, business, usa

Cambridge Biotech To Sell Retroviral Diagnostic Business

Article | 15 April 1996

Cambridge Biotech of the USA is selling its retroviral diagnostic business to bioMerieux Vitek, part of bioMerieux of France, for $6.5 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in